Navigation Links
STERIS Corporation Promotes Timothy L. Chapman to Group President of Healthcare
Date:2/5/2008

MENTOR, Ohio, Feb. 5 /PRNewswire-FirstCall/ -- STERIS Corporation (NYSE: STE) today announced that Timothy L. Chapman has been promoted to senior vice president and group president, Healthcare. Mr. Chapman joined the Company in January 2006, as senior vice president, Business Strategy. In his new role, Chapman replaces Charles L. Immel, who has decided to pursue other opportunities outside the Company.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080205/CLTU061 )

Chapman, age 45, will report to Walt Rosebrough, president and chief executive officer, and will have responsibility for the Company's Healthcare segment, a leading provider of infection prevention and surgical equipment, consumables and services to customers such as acute care hospitals and outpatient surgical centers. Mr. Chapman will also retain responsibility for the Company's existing business strategy functions.

"We are very fortunate to have a top performer like Tim for such a significant role in the Company," said Walt Rosebrough, president and chief executive officer of STERIS. "Tim has considerable experience in healthcare, not only at STERIS, but across the industry and has a deep understanding of the market and our customers. I am confident that Tim will bring considerable perspective and leadership to his new role. Chuck Immel has made a number of contributions to STERIS Corporation over the past seven years and we all wish him the best in his career beyond STERIS."

During his time at STERIS, Mr. Chapman has had responsibility for leading STERIS's strategic planning, business development and supply chain management activities where he has established greater d
'/>"/>

SOURCE STERIS Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
2. STERIS Corporation Announces Date of Fiscal 2008 Second Quarter Earnings Release and Conference Call
3. STERIS Corporation Announces Fiscal 2008 Second Quarter Results
4. STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call
5. STERIS Corporation Declares Regular Quarterly Dividend
6. STERIS Corporation Announces Fiscal 2008 Third Quarter Results
7. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
8. Brooke Franchise Corporation Announces Selected July Results
9. MedThink Communications Retained by NanoBio Corporation
10. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
11. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... ANGELES A noninvasive optical imaging device developed ... that later occur in the brain and are ... preliminary results from investigators conducting a clinical trial ... findings July 15 in an oral presentation at ... Denmark. They also were invited by conference organizers ...
(Date:7/13/2014)... Columbus, OH (PRWEB) July 13, 2014 ... Lipitor bellwether trial has been scheduled in July of ... The Lipitor lawsuits are in the discovery process ... Judge Richard M. Gergel is presiding over the multidistrict ... were filed on behalf of individuals who allege that ...
(Date:7/13/2014)... ECS is being founded by Seattle ... a special needs child, I have become keenly aware ... contemporary special education resources and evidence-based instruction. Emerald City ... families in the Seattle metro area that are looking ... We welcome the opportunity to serve our community and ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 According to ... this is a comprehensive program that teaches people how ... peripheral neuropathy without medications. This program also provides ... symptoms of peripheral neuropathy , including numbness, prickling, burning, ... its review that this home treatment program can help ...
(Date:7/12/2014)... 13, 2014 According to the new ... Systems, Airborne Systems, and Naval Systems) - Global Forecasts ... Security and Surveillance Radar market are estimated to be ... a CAGR of 5.97% to reach $8.61 billion by ... with 47 figures spread through 161 pages and in-depth ...
Breaking Medicine News(10 mins):Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 3Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 2Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 3Health News:Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial 4Health News:New Private School, Emerald City School, Founded in Downtown Seattle Now Accepting 1st to 6th Grade Students Who Learn Differently 2Health News:The Peripheral Neuropathy Program Review Exposes Randall Labrum's Peripheral Neuropathy Treatment Program – Vkool.com 2Health News:The Peripheral Neuropathy Program Review Exposes Randall Labrum's Peripheral Neuropathy Treatment Program – Vkool.com 3Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 4
... likely to display abnormal social behaviour and make poor ... according to research in the January issue of the ... of studies have already associated pathological gambling with Parkinson,s, ... associated mainly with dopamine replacement therapy. Researchers ...
... and tendons work together to provide the perfect balance ... Institute scientists show that this partnership begins in the ... study, published in a recent issue of Developmental ... and bones that drives the development of a strong ...
... cholesterol-lowering effect, study suggests , THURSDAY, Jan. 14 (HealthDay ... effect of statin drug therapy on the risk of ... , Much of the benefit from statins such as ... lowering of blood levels of "bad" LDL cholesterol, the ...
... EUGENE, Ore. , Jan. 14 The Tech-Aid ... unprecedented work, has released another interactive CD-ROM for people with ... Disabilities. , With AIDS being the fifth leading cause of ... United States , this interactive computer program helps women with ...
... ... of the industry’s leading hospitality installation companies. JK Logistical Operations was founded by ... operations offices in Dallas and Denver. , ... Chicago, IL (PRWEB) January 14, 2010 -- JK Logistical Operations ...
... ... allows increased coatings development ,capacity., , ... Horsham, PA (PRWEB) January 14, 2010 -- Biocoat, Inc., maker of ... that allows increased coatings development capacity. Biocoat and DipTech Systems, Inc. cooperated ...
Cached Medicine News:Health News:Parkinson's patients who are pathological gamblers also display abnormal social behavior 2Health News:Weizmann Institute scientists reveal how tendons shape developing bones 2Health News:More Evidence That Statins Cut Stroke Risk 2Health News:More Evidence That Statins Cut Stroke Risk 3Health News:The Tech-Aid Institute Releases HIV/AIDS Prevention Software for Women with Intellectual Disabilities 2Health News:JK Logistical Operations Acquires JDL Installation Logistics 2
(Date:7/10/2014)... 10, 2014   Ventana Medical Systems, Inc.  (Ventana), ... has entered into an agreement with Merck KGaA, Darmstadt, ... Serono in the United States ... Merck KGaA,s biopharmaceutical division on the development and commercialization ... using Ventana,s proprietary diagnostic assays. In alignment with Merck ...
(Date:7/10/2014)... , July 10, 2014 Decision Resources Group ... of the U.S. Food and Drug Administration,s (FDA) approval ... binder Velphoro, which was approved by the FDA in ... kidney disease (CKD) patients on dialysis. Other ... Nephrology (US) Q2 2014 : ...
(Date:1/15/2014)...  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the ... Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... in order to treat dental impairments, for tooth restoration ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: